TrialBritish journal of cancer2019

A multi-national, randomised, open-label, parallel, phase III non-inferiority study comparing NK105 and paclitaxel in metastatic or recurrent breast cancer patients.

Yasuhiro Fujiwara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.